Scientists at Rutgers University have developed a targeted drug delivery system that they believe could make ovarian cancer more treatable and increase survival rates for the most
deadly gynecological cancer in the United States.
Not exact matches
Now a new clinical trial is under way, by New York's Mount Sinai, to test a vaccine to combat recurrence in some of the most
deadly forms of
cancer, including lung, breast,
gynecological and bladder
cancers.
Mount Sinai is testing a «personalized» vaccine, aimed at combating recurrence in some of the most
deadly forms of
cancer, including lung, breast,
gynecological and bladder
cancers.
The fifth - leading cause of
cancer death in the United States and the most
deadly of
gynecological cancers, it killed more than 14,000 American women in 2014, according to the Centers for Disease Control and Prevention.